|
PMN
|
ProMis does not need Biogen. All PMN needs is the FDA approving the Abeta...
|
|
PMN
|
Gbathat...Exactly right. And so as the 8 million PMN shares that got bought...
|
|
T.RVX
|
As they say, buy the stock on the rumor, Sell on the News. Can't...
|
|
T.RVX
|
Let's keep our eye on the ball "Apabetalone (RVX-208) Reduces...
|
|
T.RVX
|
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal...
|
|
V.QPT
|
November 9, 2020: Quest Announces that OncoQuest Pharmaceuticals Inc...
|
|
PMN
|
What we need is for FDA to approve Biogen's Aducanumab and that would be...
|
|
PMN
|
But Biogen hits snag : https://www.cnbc.com/2020/11/06/biogen-suffers-setback...
|
|
BIOAF
|
FYI: Breaking News: World-first clinical trial for the treatment of...
|
|
T.RVX
|
Resverlogix Reports Filing of New Intellectual Property on Key Renal...
|
|
V.NSP.H
|
This Cavaltinib treatment for COVID-19 will be needed for years to come with...
|
|
T.RVX
|
But how do you deal with the big elephant in the room out of China that no...
|
|
PMN
|
"Or, Aducanumab's failure reduces any potential interest in PMN"...
|
|
PMN
|
PMN may succeed either way. - If aducanumab fails NDA...
|
|
V.WATR
|
Excellent movie on Netflix "Brave Blue World" ...racing to...
|
|
V.SPP
|
SPOT COFFEE (CANADA) LTD. ("SPP") BULLETIN TYPE: Reinstated for...
|
|
T.RVX
|
If we're going to dream, let's dream big..haha! G1945V
|
|
T.RVX
|
A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone...
|
|
BIOAF
|
How did Zacks ever come up with a valuation of USD $0.60 per share? Does...
|
|
V.NSP.H
|
broke,.......... thank you for the feedback. I assume there is a lot...
|